2. Bell D, Nicoll A, Fukuda K, et al. Non-pharmaceutical interventions for pandemic influenza, national and community measures. Emerg Infect Dis 2006;12:88–94.

3. Torner N, Soldevila N, Garcia JJ, et al. Effectiveness of non-pharmaceutical measures in preventing pediatric influenza: a case-control study. BMC Public Health 2015;15:543.

4. Gokmen Y, Baskici C, Ercil Y. Effects of non-pharmaceutical interventions against COVID-19: a cross-country analysis. Int J Health Plann Manage 2021;36:1178–1188.

5. Sachs J, Schmidt-Traub G, Kroll C, Lafortune G, Fuller G, Woelm F. Sustainable development report 2020. Cambridge: Cambridege Books, 2021. 6. Heymann DL, Shindo N. COVID-19: what is next for public health? Lancet 2020;395:542–545.

7. Adegbija O, Walker J, Smoll N, Khan A, Graham J, Khandaker G. Notifiable diseases after implementation of COVID-19 public health prevention measures in Central Queensland, Australia. Commun Dis Intell 2018;2021:45.

8. Ullrich A, Schranz M, Rexroth U, et al. Impact of the COVID-19 pandemic and associated non-pharmaceutical interventions on other notifiable infectious diseases in Germany: an analysis of national surveillance data during week 1–2016 - week 32–2020. Lancet Reg Health Eur 2021;6:100103.

9. Lai CC, Chen SY, Yen MY, Lee PI, Ko WC, Hsueh PR. The impact of the coronavirus disease 2019 epidemic on notifiable infectious diseases in Taiwan: a database analysis. Travel Med Infect Dis 2021;40:101997.

10. Chen B, Wang M, Huang X, et al. Changes in incidence of notifiable infectious diseases in china under the prevention and control measures of COVID-19. Front Public Health 2021;9:728768.

11. Geng MJ, Zhang HY, Yu LJ, et al. Changes in notifiable infectious disease incidence in China during the COVID-19 pandemic. Nat Commun 2021;12:6923.

12. R Core Team. R: a language and environment for statistical computing [Internet] Vienna: R Foundation for Statistical Computing, c2020. [cited 2024 Jul 19]. Available from: http://www.r-project.org/index.html. 13. Geng Y, Zhang L. Impact of non-pharmaceutical interventions during COVID-19 pandemic on pertussis, scarlet fever and hand-foot-mouth disease in China. J Infect 2022;84:e13–e15.

14. Kim DH, Nguyen TM, Kim JH. Infectious respiratory diseases decreased during the COVID-19 pandemic in South Korea. Int J Environ Res Public Health 2021;18:6008.

15. Tan HMJ, Tan MS, Chang ZY, et al. The impact of COVID-19 pandemic on the health-seeking behaviour of an Asian population with acute respiratory infections in a densely populated community. BMC Public Health 2021;21:1196.

16. Sun X, Xu Y, Zhu Y, Tang F. Impact of non-pharmaceutical interventions on the incidences of vaccine-preventable diseases during the COVID-19 pandemic in the eastern of China. Hum Vaccin Immunother 2021;17:4083–4089.

17. Shah AP, Smolensky MH, Burau KD, Cech IM, Lai D. Seasonality of primarily childhood and young adult infectious diseases in the United States. Chronobiol Int 2006;23:1065–1082.

18. Sabale U, Jarmale L, Murtagh J, Pawaskar M, Bencina G. Impact assessment of immunization and the COVID-19 pandemic on varicella across Europe using digital epidemiology methods: a descriptive study. PLoS One 2023;18:e0283465.

19. O’Toole RF. The interface between COVID-19 and bacterial healthcare-associated infections. Clin Microbiol Infect 2021;27:1772–1776.

20. Silva ARO, Salgado DR, Lopes LPN, Castanheira D, Emmerick ICM, Lima EC. Increased Use of antibiotics in the intensive care unit during coronavirus disease (COVID-19) pandemic in a Brazilian hospital. Front Pharmacol 2021;12:778386.

21. Yamamoto N, Asada R, Kawahara R, et al. Prevalence of, and risk factors for, carriage of carbapenem-resistant Enterobacteriaceae among hospitalized patients in Japan. J Hosp Infect 2017;97:212–217.

23. La Y, Hong JY, Lee HS, et al. Increase of multidrug-resistant bacteria after the COVID-19 pandemic in South Korea: time-series analyses of a long-term multicenter cohort. J Infect 2022;85:702–769.

24. Huh K, Jung J, Hong J, et al. Impact of nonpharmaceutical interventions on the incidence of respiratory infections during the coronavirus disease 2019 (COVID-19) outbreak in Korea: a nationwide surveillance study. Clin Infect Dis 2021;72:e184–e191.

25. KDCA. Epidemiological investigation of infectious diseases in Republic of Korea annual report 2019. Osong: KDCA, 2021. 26. Potasman I, Paz A, Odeh M. Infectious outbreaks associated with bivalve shellfish consumption: a worldwide perspective. Clin Infect Dis 2002;35:921–928.

27. Maheshwari A, Ray S, Thuluvath PJ. Acute hepatitis C. Lancet 2008;372:321–332.